Interlock
Payments companies reported to CMS as associated with Interlock. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Interlock, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Interlock
These are the largest totals companies reported as associated with Interlock. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nariman Nezami | Baltimore, MD | Vascular & Interventional Radiology | $458.84 |
| David Song | Elmhurst, NY | Internal Medicine | $296.87 |
| Ramesh Gowda | New York, NY | Interventional Cardiology | $288.63 |
| Hugo Rosero | New York, NY | Cardiovascular Disease | $275.24 |
| Michael Dudkiewicz | New York, NY | Vascular Surgery | $273.54 |
| James Mckinsey | New York, NY | Vascular Surgery | $267.07 |
| Yamama Hafeez | Apple Valley, CA | Interventional Cardiology | $262.56 |
| Ari Mintz | New York, NY | Interventional Cardiology | $252.56 |
| Vahid Etezadi | Baltimore, MD | Vascular & Interventional Radiology | $242.28 |
| Howard Richard | Baltimore, MD | Vascular & Interventional Radiology | $202.23 |
Prescribed Interlock?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.